Biotech Is Finally Rallying. Why Mizuho’s Jared Holz Is Optimistic This Time.

新聞報導於1天前

撰寫摘要中...

您可能也對這些小見聞有興趣

5 Dividend Aristocrats Proving That Reliability Still Pays in 2025

Why is Nebius Group (NBIS) Surging?

Gas prices could stay below $3 'through the holidays': Expert

Novo Nordisk hires US pharma veteran as Trump pricing pressure mounts

Tesla Q3 earnings: What investors anticipate from CEO Elon Musk

The latest source of market turmoil: credit-strapped regional banks

Nearly 80% of US workers have been victims of ‘career catfishing’ — here’s what it is and how to vet your next employer

AP Top Financial News at 12:57 a.m. EDT

Indian engineering firm Tata Tech's profit rises on non-core business boost

CVS Health Corporation (CVS): A Must-Buy Dividend Stock Leading U.S. Pharmacy and Healthcare

返回所有小見聞